PDS Biotechnology
PDSB
PDSB
65 hedge funds and large institutions have $47.9M invested in PDS Biotechnology in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 25 increasing their positions, 11 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
65
Holders Change
+6
Holders Change %
+10.17%
% of All Funds
1%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
20
Increased
25
Reduced
11
Closed
13
Calls
$1.53M
Puts
$1.01M
Net Calls
+$522K
Net Calls Change
-$1.01M
Top Buyers
| 1 |
1
Two Sigma Investments
New York
|
$3.91M |
| 2 |
2
Millennium Management
New York
|
$743K |
| 3 |
3
Renaissance Technologies
New York
|
$3.6M |
| 4 |
4
First Manhattan
New York
|
$2.2M |
| 5 |
SCA
5
Sassicaia Capital Advisers
Jericho,
New York
|
$609K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
UBS Group
Zurich,
Switzerland
| – | -$44K | -2,946 | Closed |
|
|
AWA
77
Arkadios Wealth Advisors
Atlanta,
Georgia
| – | -$7K | -500 | Closed |
|